Showing posts with label accurate stock tips. Show all posts
Showing posts with label accurate stock tips. Show all posts
Monday, 5 August 2019
Closing Bell By CapitalStars 05/August/2019
03:32
accurate Intraday Tips, accurate stock tips, Agri commodity Tips, Cash intraday tips, closing bell
1 comment
DAILY NIFTY SMART MOVERS
Company Name LTP %Change High Low Prev.Close
BHARTI AIRTEL 359.10 4.53 361.65 339.05 343.55
TECHM 649.85 4.43 651.05 625.30 636.15
BAJAJ AUTO 2641.90 1.59 2642.65 2545.50 2600.55
COALINDIA 200.30 1.57 202.9 193.10 197.20
TCS 2240 1.57 2199.90 2252.25 2195.60 2205.30
DAILY NIFTY TOP LAGGARDS
Company Name LTP %Change High Low Prev.Close
YESBANK 81.05 -8.21 88 79.50 88.30
UPL 539.90 -5.86 568.95 535.45 573.50
TATAMOTOR 124 -5.13 128.20 122.30 130.70
POWERGRID 200.65 -4.70 210.00 196.85 210.55
GRASIM 747 -3.98 772.90 746.65 778
Financial
Advisory Company in Indore, Stock
Advisory Company in Indore, Equity Tips, FreeTrading Tips , MCX Tips, sebi registered advisory company, Intraday
stock tips, Free
commodity tips
Investment trading in securities market is
always subjected to market risks, past performance is not a guarantee of future
performance. CapitalStars Investment Adviser: SEBI Registration Number:
INA000001647
For more details call
on 9977499927 or visit our website www.capitalstars.com
Sunday, 4 August 2019
Opening Bell By CapitalStars 05/August/2019
21:12
accurate Intraday Tips, accurate stock tips, advisory company in indore, BSE, Free Stock Market Tips, opening bell
No comments
CS NIFTY FUTURES (AUG) OVERVIEW
TREND BEARISH
RES 2: 11300
RES 1: 11150
SUP 1: 10800
SUP 2: 10650
CS BANK NIFTY FUTURES (AUG) OVERVIEW
TREND BEARISH
RES 2: 28650
RES 1: 28200
SUP 1: 27675
SUP 2: 27200
Financial
Advisory Company in Indore, Stock
Advisory Company in Indore, Equity Tips, FreeTrading Tips , MCX Tips, sebi registered advisory company, Intraday
stock tips, Free
commodity tips
Investment trading in securities market is
always subjected to market risks, past performance is not a guarantee of future
performance. CapitalStars Investment Adviser: SEBI Registration Number:
INA000001647
For more details call
on 9977499927 or visit our website www.capitalstars.com
Friday, 2 August 2019
CORPORATE NEWS By CapitalStars 02/August/2019
03:41
accurate Intraday Tips, accurate stock tips, commodity tips, corporate news, Intraday tips, MCX Tips
No comments
Exide Industries net profit at Rs224cr in Q1
Exide Industries Limited, on Friday, reported that its Q1FY20 net profit has risen by 7% to Rs224.29cr from Rs209.92cr for the corresponding quarter ended June 30, 2018.
However, revenue stood flat in Q1 at Rs2, 779.25cr as against Rs2, 772.46cr for the corresponding quarter ended June 30, 2018.
EBITDA came up by 4% at Rs407.7cr in Q1.
G Chatterjee, MD & CEO said that demand of Automotive Batteries remains under pressure while growth in UPS, Telecom, as well as other Infrastructure segments, continued during the first quarter.
HDFC spurts 2.5% after Q1 net profit jumps 46%
Shares of Housing Development Finance Corporation (HDFC) soared 2.5% in the afternoon session after the company has reported 46% jump in its Q1FY20 net profit at Rs3, 203cr as against Rs2, 190cr in the same quarter last year.
Revenue was up 30.6% at Rs12, 990cr in Q1FY20 as against Rs9, 947.35cr for the corresponding quarter ended June 30, 2018.
NII in Q1 stood at Rs2, 739cr, as per the filing. The company's loan book grew 11.2% at Rs4.16 lakh cr. Gross NPAs were up marginally at 1.29% against 1.22% on a qoq basis.
Power Grid PAT at Rs2428cr in Q1FY20
Power Grid Corporation posted its standalone net profit for the first quarter at Rs2,428cr, which was up by 8% against Rs2,241.7cr in Q1FY19.
Revenue from operations rose by 8% to Rs8,804cr in Q1FY20 as against Rs8,130.7cr for the corresponding quarter ended June 30, 2018.
EBITDA was up 13.9% at Rs7,897cr in Q1.
Zydus completes Phase-III trials of Saroglitazar Magnesium in Type-2 Diabetes MellitusZydus completes Phase-III trials of Saroglitazar Magnesium in Type-2 Diabetes Mellitus
Zydus Cadila announced that it has completed Phase 3 Clinical Trial in India of Saroglitazar Mg for treating Type 2 Diabetes. The trial was a multi-centric, randomized, double blind study to evaluate the safety and efficacy of 2mg and 4mg of Saroglitazar compared to Pioglitazone 45mg in patients with Type 2 Diabetes Mellitus. The Phase 3 trial enrolled 1140 subjects and studied the patients over a period of 56 weeks.
The primary outcome of the trial was a change from baseline in glycosylated haemoglobin (HbAlc) for Saroglitazar 4 mg, 2 mg and Pioglitazone 30 mg at 24 weeks. The study also measured glycosylated haemoglobin (HbAlc) and other secondary outcome measures including fasting plasma glucose, Triglyceride (TG) cholesterol, Low Density Lipoprotein (LDL) cholesterol, Very Low Density Lipoprotein (VLDL) cholesterol, High Density Lipoprotein (HDL) cholesterol, Total Cholesterol (TC) cholesterol, Non HDL cholesterol, Apolipoprotein (Apo) Al, Apo B between Saroglitazar 4 mg, 2 mg and Pioglitazone 30 mg at Week 12, Week 24, and Week 56.
Marico rises 3% on healthy Q1 numbers
Marico is trading up 1.5% after posting health Q1 earnings yesterday.
Revenue from operations grew 7% yoy to Rs2,166cr with an underlying domestic volume growth of 6% and constant currency growth of 7% in the international business.There was a one-time trade inventory correction in the Gulf business. Adjusting for the same, constant currency growth in the International business stood at 9%.Easing raw material costs in the domestic and key overseas markets led to gross margin expansion of 524bps on a yoy basis.
EBITDA margin expanded 324 bps, as the Company stepped up A&P spends by 32% to support its core and new franchises.
Financial
Advisory Company in Indore, Stock
Advisory Company in Indore, Equity Tips, FreeTrading Tips , MCX Tips, sebi registered advisory company, Intraday
stock tips, Free
commodity tips
Investment trading in securities market is
always subjected to market risks, past performance is not a guarantee of future
performance. CapitalStars Investment Adviser: SEBI Registration Number:
INA000001647
For more details call
on 9977499927 or visit our website www.capitalstars.com
Thursday, 1 August 2019
CORPORATE NEWS By CapitalStars 01/August/2019
Marico's adj. PAT up 26% yoy to Rs320cr for Q1FY20
Marico reported strong earnings growth for Q1FY20.
Revenue from operations grew 7% yoy to Rs2,166cr with an underlying domestic volume growth of 6% and constant currency growth of 7% in the international business.There was a one-time trade inventory correction in the Gulf business. Adjusting for the same, constant currency growth in the International business stood at 9%.
Easing raw material costs in the domestic and key overseas markets led to gross margin expansion of 524bps on a yoy basis.
EBITDA margin expanded 324 bps, as the Company stepped up A&P spends by 32% to support its core and new franchises.
RBI Monetary Policy Preview: Expecting a 25bps rate cut
Since the last policy, data and trends emerging indicate that inflation continues to be stable and is trending on the lower side. Further, growth has been muted on account of visible consumption slowdown as well as subdued investment outlook. Despite a late start, we have seen that the monsoon has reasonably caught up, which should give a boost to agriculture and lead to the revival to some extent of consumption in rural India. Globally, we have seen negative yields in certain countries and overall interest rates are stable or dropping and growth has slowed.
Against this backdrop, the central bank is likely to cut the repo rate by 25 bps. It will be important to study the policy narrative to get a direction of likely future action by the RBI, liquidity measures, any other structural changes etc. Suffice it to say that inflation will be the central theme balanced with the need to boost growth.
CEAT's PAT for Q1 up 15.1% yoy at Rs82cr
For Q1FY20, CEAT's net revenue from operations increased by 1.7% yoy at Rs1,752cr from Rs1,722cr in Q1FY19.
Gross margin contracted to 39.5% from 39.9%.
EBITDA stood at Rs172cr in Q1FY20 vs. Rs181cr in Q1FY19; margins came in at 9.8% during the quarter under review from 10.5% in the corresponding quarter previous year.
The company's PAT for Q1FY20 came in at Rs82cr compared to Rs71cr in Q1FY19.
Debt / equity stood at 0.57x compared to 0.28x in Q1FY19.
Biocon, Mylan launch first Trastuzumab Biosimilar, Ogivri, in Australia
Biocon Ltd. and Mylan N.V. announced the launch in Australia of Ogivri (trastuzumab), a biosimilar to Herceptin 1 (trastuzumab), for the treatment of HER2-overexpressing breast cancer and metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma).
Ogivri is the first trastuzumab biosimilar approved and launched in Australia and available on the Pharmaceutical Benefits Scheme (PBS). Biosimilars generate savings that help manage the growing costs of Australia health care system, particularly the PBS. They enable greater patientâ access to necessary treatments and free up funding for the listing of the latest treatments.
Godrej Consumer Products up 2%; reports Rs291cr adj. PAT for Q1FY20
Godrej Consumer Products reported its Q1FY20 numbers today.
The cons. net profit came in at Rs408cr, just 1% yoy higher than that in Q1FY19. Without exceptional and one-off items, it stood at Rs291cr and vs. Rs313cr in Q1FY20.
The company's net sales on a constant currency basis grew 4% yoy. Its India business sales grew 1% yoy and 5% yoy in volume terms.
International business sales grew 9% yoy, on a constant currency basis
The consolidated constant currency EBITDA rose 8% yoy to Rs301cr.
Financial
Advisory Company in Indore, Stock
Advisory Company in Indore, Equity Tips, FreeTrading Tips , MCX Tips, sebi registered advisory company, Intraday
stock tips, Free
commodity tips
Investment trading in securities market is
always subjected to market risks, past performance is not a guarantee of future
performance. CapitalStars Investment Adviser: SEBI Registration Number:
INA000001647
For more details call
on 9977499927 or visit our website www.capitalstars.com
Wednesday, 31 July 2019
Closing Bell By CapitalStars 31/July/2019
DAILY NIFTY SMART MOVERS
SCRIPTS PRICE PRE. CLOSE CHANGE (%) CHANGE (Rs.) VOLUME
TVS Motor
369.00 344.70 7.05 24.30 200.18
Yes Bank
91.30 86.10 6.04 5.20 9791.81
Indusind Bank
1408.00 1336.90 5.32 71.10 323.04
Indian Oil Corp.
139.30 133.55 4.31 5.75 807.21
Tata Steel
431.90 414.70 4.15 17.20 599.24
DAILY NIFTY TOP LAGGARDS
SCRIPTS PRICE PRE. CLOSE CHANGE (%) CHANGE (Rs.) VOLUME
Zee Entertainment
361.45 381.20 -5.18 -19.75 885.49
Bajaj Hold & Invest
3398.50 3569.50 -4.79 -171.00 1.59
Axis Bank
674.40 706.55 -4.55 -32.15 1271.02
Biocon
226.70 234.25 -3.22 -7.55 235.42
Shree Cement
20200.00 20800.10 -2.89 -600.10 1.13
BEST CALL OF THE DAY (FINAL TG )
NIFTY FUTURE
SELL BANK NIFTY FUT FINAL TGT
FUTURE INTRADAY
SELL TITAN FUT FINAL TGT
SELL DIVISLAB FUT FINAL TGT
CASH INTRADAY
SELL DIVISLAB IN CASH FINAL TGT
Financial
Advisory Company in Indore, Stock
Advisory Company in Indore, Equity Tips, FreeTrading Tips , MCX Tips, sebi registered advisory company, Intraday
stock tips, Free
commodity tips
Investment trading in securities market is
always subjected to market risks, past performance is not a guarantee of future
performance. CapitalStars Investment Adviser: SEBI Registration Number:
INA000001647
For more details call
on 9977499927 or visit our website www.capitalstars.com
CORPORATE NEWS By CapitalStars 31/July/2019
03:31
accurate Intraday Tips, accurate stock tips, advisory company in indore, corporate news, eqity tips
No comments
Apollo Tyres net profit declines 44% yoy in Q1FY20
Apollo Tyres' share price jumped 4% after the co. announced its Q1FY19 numbers.
The company's Q1FY20 net profit has declined by 44% to Rs141.6cr from Rs251.8cr for the corresponding quarter ended June 30, 2018.
The income from operations rose by 1% to Rs4331.3cr in Q1FY20 as against Rs4299.3cr for the corresponding quarter ended June 30, 2018.
EBITDA margin stood at 11% vs. 12.5% yoy basis.
Coffee Day appoints S. V. Ranganath as interim chairman
Coffee Day Enterprises said in the press note that the board has appointed SV Ranganath as the new Interim Chairman. The company has also appointed Nitin Bagmane as an Interim Chief Operating Officer.
Constitution of an executive committee comprising S. V. Ranganath (Non-Executive Independent Director), Nitin Bagmane (COO) and R. Ram Mohan (CFO) to exercise the powers previously vested with the Chief Executive Officer of the Company and the Administrative Committee constituted by the Board in 2015. The Board will, in due course, prepare a detailed charter of authorities vested in the Executive Committee and approve the same. The Executive Committee will, inter alia, explore opportunities to deleverage the Coffee Day Group, the company said in the stock exchange.
RBI eases ECB norms for corporates, NBFCs
The Reserve Bank of India (RBI) on July 30 relaxed the end-use stipulations under external commercial borrowings framework for corporates and non-banking financial companies (NBFCs).
"Based on the feedback from stakeholders and with a view to further liberalise the ECB framework, it has been decided, in consultation with the Government of India, to relax the end-use restrictions relating to external commercial borrowings for working capital requirements, general corporate purposes and repayment of rupee loans," RBI said in a press release yesterday.
PNB Housing Finance PAT up 11% yoy to Rs285cr in quarter ended Jun'19
Performance highlights for Q1FY20 vs. Q1FY19:
Its Net Interest Income registered a growth of 45% to Rs625.5cr from Rs432.8cr.
Profit after Tax grew by 11% to Rs284.5cr from Rs255.8cr.
The spread on loans for Q120 stood at 2.53% compared to 2.11% for Q1FY19.
Net Interest Margin for Q1FY20 stood at 3.14% compared to 2.74% for Q1FY9.
Return on Asset is at 1.37% on an average gearing of 9.4x against 1.54% on an average gearing of 8.7x during Q1 FY18-19 resulting in a Return on Equity of 14.8% for Q1 FY19-20 vis a vis 15.8%for Q1 FY18-19.
Gross Non-Performing Assets (GNPA) stood at 0.85% of the loan assets as on 30th June, 2019, against 0.43% as on 30th June, 2018.
Net NPA stood at 0.67% of the loan assets as on 30th June, 2019 against 0.33% as on 30th June, 2018.
ICRA expects some weakening in Retail-NBFC asset quality in the current fiscal
The assets under management (AUM) of retail non-banking finance companies grew at a much slower pace of ~9.5% (over September 2018) during H2FY2019 vis a vis ~13% during H2FY2018 (over September 2017) due to tightening of liquidity. Typically, though Retail-NBFC growth in H2 is higher than H1, in FY2019, it was lower than H1 growth of 11.5%. Therefore, overall credit growth of 22% during FY2019 was largely supported by the H1 performance. The Retail-NBFC AUM stood at Rs9.1 trillion as on March 31, 2019.
Financial
Advisory Company in Indore, Stock
Advisory Company in Indore, Equity Tips, FreeTrading Tips , MCX Tips, sebi registered advisory company, Intraday
stock tips, Free
commodity tips
Investment trading in securities market is
always subjected to market risks, past performance is not a guarantee of future
performance. CapitalStars Investment Adviser: SEBI Registration Number:
INA000001647
For more details call
on 9977499927 or visit our website www.capitalstars.com
Tuesday, 30 July 2019
CORPORATE NEWS By CapitalStars 30/July/2019
03:38
accurate Intraday Tips, accurate stock tips, advisory company in indore, corporate news, eqity tips
No comments
Dr. Reddy's Labs launches Pregabalin capsules in the US
Dr Reddys Laboratories announced the launch of Pregabalin capsules in the US market.Shares of the company are down 2.5%.Pregabalin Capsules is a therapeutic equivalent generic version of Lyrica® (pregabalin) Capsules approved by the US Food and Drug Administration (USFDA).
The Lyrica® (pregabalin) Capsules brand had US sales of ~$5,462mn MAT for the most recent twelve months ending in May 2019, according to IQVIA Health.
Dr. Reddy's Pregabalin Capsules are available in 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg capsules in bottle count sizes of 90. This is also a controlled substance schedule V product.
Bank of India stock slumps 6% even as net profit jumps 154% yoy to Rs243cr
Shares of Bank of India are down 6% even as its PAT for the quarter ending Jun'19 more than doubled over it year-ago profit.
Net profit up 154% at Rs242.6cr vs. Rs 95.1cr yoy.
Its net interest income (NII) grew 3.9% yoy at Rs3, 485.4cr against Rs3, 354.3cr in the corresponding period last year.Gross NPA came in at 16.50% and net NPA at 5.79% qoq.
Dilip Buildcon declared L-1 bidder for Khaki dam construction
Dilip Buildcon Limited has been declared L-1 bidder for the project involving construction of Kharkai Dam at Icha with all control gates and its allied works including civil, mechanical (with Design of Gates), electrical and SCADA system under SMP in the state of Jharkhand.
The Company has been declared L-1 bidder by the Water Resources Department for the project in the state of Jharkhand.
The project cost is Rs972cr, and the completion period is 26 months.
ICRA expects some weakening in Retail-NBFC asset quality in the current fiscal
The assets under management (AUM) of retail non-banking finance companies grew at a much slower pace of ~9.5% (over September 2018) during H2FY2019 vis a vis ~13% during H2FY2018 (over September 2017) due to tightening of liquidity. Typically, though Retail-NBFC growth in H2 is higher than H1, in FY2019, it was lower than H1 growth of 11.5%. Therefore, overall credit growth of 22% during FY2019 was largely supported by the H1 performance. The Retail-NBFC AUM stood at Rs9.1 trillion as on March 31, 2019.
Granules India net profit soars 61% yoy in Q1
Granules India Ltd., a growing pharmaceutical manufacturing company, announced today the result for its first quarter of the financial year 2020. The stock gained after the company reported healthy Q1 numbers on Tuesday.
The company's Q1FY20 net profit has increased by 61% to Rs83cr from Rs52cr for the corresponding quarter ended June 30, 2018.
The income from operation also rose by 31% to Rs595cr in Q1 as against Rs453cr for the corresponding quarter ended June 30, 2018.
Financial
Advisory Company in Indore, Stock
Advisory Company in Indore, Equity Tips, FreeTrading Tips , MCX Tips, sebi registered advisory company, Intraday
stock tips, Free
commodity tips
Investment trading in securities market is
always subjected to market risks, past performance is not a guarantee of future
performance. CapitalStars Investment Adviser: SEBI Registration Number:
INA000001647
For more details call
on 9977499927 or visit our website www.capitalstars.com
Monday, 29 July 2019
Market Live By CapitalStars 30/July/2019
21:12
accurate Intraday Tips, accurate stock tips, advisory company in indore, Agri commodity Tips, auto stock, Market live
No comments
Nifty likely to open higher.
The Nifty50 is likely to open higher on Tuesday following Asian markets which were trading with a positive bias as equity investors are building in hopes for an expected U.S. interest rate cut this week. The U.S. Federal Reserve begins a two-day policy meeting later on Tuesday, at which it is widely expected to lower interest rates by 25 basis points. If implemented, it would be the central bank first rate cut in a decade, said a Reuters report. The Dow Jones Industrial Average rose 28.96 points to 27,221.41, the S&P 500 lost 4.88 points to 3,020.98, and the Nasdaq Composite dropped 36.88 points, to 8,293.33. Trends on SGX Nifty indicate a positive opening for the broader index in India, with 0.22 percent gain or 25 points. Nifty futures were trading around 11,236-level on the Singaporean Exchange.
Global Market:
Asian Markets: Asian markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.68% while the Hang Seng is up 0.51%. The Shanghai Composite is not trading.
US Markets: North and South American markets finished mixed as of the most recent closing prices. The IPC gained 1.48% and the Bovespa rose 0.65%. The S&P 500 lost 0.16%.
European Markets: European markets finished mixed as of the most recent closing prices. The FTSE 100 gained 1.82%, while the CAC 40 led the DAX lower. They fell 0.16% and 0.02% respectively.
Major Headlines of the day:
Rupee stands at 68.75 per dollar.
DLF's Q1FY20 net profit soars 140% yoy to Rs413cr Net sales of Rs705cr in this quarter have been achieved and the co. expects this momentum to continue.
Strides Pharma adj. PAT at Rs52.3cr in Q1FY20 For the quarter, EBITDA stood at Rs123.9cr, a growth of 155% yoy vs. Rs48.6cr over the corresponding quarter of the previous year.
Earnings Reaction To Watch
AXISBANK
BANK OF INDIA
CHOLAMANDALAM
DISHTV
GRANUELS
GULF OIL LUBRIC
HEROMOTOCO
NMDC
ORIENT ELECTRIC
PEL
PNB HOUSING FIN
TECH MAHINDRA
VIP INDUSTRIES
Trend in FII flows:- The FIIs were Net Value of Rs -704.42 segment while the DIIs were Net Value of 1351.64 the provisional figures.
Financial
Advisory Company in Indore, Stock
Advisory Company in Indore, Equity Tips, FreeTrading Tips , MCX Tips, sebi registered advisory company, Intraday
stock tips, Free
commodity tips
Investment trading in securities market is
always subjected to market risks, past performance is not a guarantee of future
performance. CapitalStars Investment Adviser: SEBI Registration Number:
INA000001647
For more details call
on 9977499927 or visit our website www.capitalstars.com
Friday, 26 July 2019
ICICI Bank likely to post strong Q1 profit with double-digit NII, loan growth
22:39
accurate Intraday Tips, accurate stock tips, advisory company in indore, CapitalStars, Cash intraday tips, corporate news, ICICI Bank
No comments
Kotak Institutional Equities as well as Prabhudas Lilladher expect 22 percent decline year-on-year and 15 percent sequential fall in provisions for bad loans.
Country's largest private sector
lender ICICI Bank July 27 is expected to report a profit in the range
of Rs 1,300-2,100 crore for the June quarter, backed by double-digit
year-on-year (YoY) growth in loan book and net interest income.
The bank had reported a loss
of Rs 119.6 crore in the June quarter last year and a profit of Rs 969.1 crore
in the March 2019 quarter.
The stock gained 1.6 percent
to close at Rs 415.50 on July 26. It has gained 51 percent over the last year
amid hope of improvement in the asset quality.
Brokerages expect Q1 net
interest income growth around 17-19 percent and loan growth around 13-15
percent YoY.
"We expect core earnings (base quarter had stake sale gains
of ICICI Life) trajectory to remain strong at around 15 percent YoY, led by
healthy loan growth (around 15 percent YoY) and better NII growth (19 percent
YoY). NIM will decline QoQ by around 10 bps due to lower one-offs," said
Kotak which expects profit at Rs 1,393.1 crore for the quarter.
Prabhudas Lilladher also said
adjusting for one-off stake sale gains of Q1FY19, core pre-provision operating
profit (PPOP) growth will be better. Loan growth will also be better than the
industry led by domestic & retail growth. NIMs, however, could be
sequentially lower on one of I-T refund impact. Core NIMs though should be
steady.
The likely double-digit YoY
and sequential fall in provisions are also expected to boost profitability.
Kotak Institutional Equities
as well as Prabhudas Lilladher expect 22 percent decline year-on-year and 15
percent sequential fall in provisions for bad loans.
Asset quality could see
further improvement sequentially on write-offs. Prabhudas Lilladher sees gross non-performing
assets as a percentage of gross advances declined to 6.61 percent in the June
quarter, against 6.7 percent in the previous quarter.
"We expect a reduction
in gross NPLs on the back of write-offs. Credit costs will decline QpQ led by
lower slippages (around less than 1.7 percent of loans, primarily from
agriculture). Below-investment-grade portfolio would decline QoQ and coverage
ratio would improve QoQ," Kotak said.
According to Motilal Oswal
also, gross slippages are expected to moderate to 2.5 percent due to a
reduction in corporate slippages. Net stress loans (including BB & below)
as on Q4FY19 stood at 5.9 percnet of loans and are expected to decline further
as incremental stress addition moderates.
Key things to watch out for
would be an outlook on asset quality and trend on further relapse from
restructured loans, and growth in CASA + retail term deposits.
Source: https://www.moneycontrol.com/news/business/earnings/icici-bank-likely-to-post-strong-q1-profit-with-double-digit-nii-loan-growth-4252041.html
Financial
Advisory Company in Indore, Stock
Advisory Company in Indore, Equity Tips, FreeTrading Tips , MCX Tips, sebi registered advisory company, Intraday
stock tips, Free
commodity tips
Investment trading in securities market is
always subjected to market risks, past performance is not a guarantee of future
performance. CapitalStars Investment Adviser: SEBI Registration Number:
INA000001647
For more details call
on 9977499927 or visit our website www.capitalstars.com
Monday, 22 July 2019
Market Live By CapitalStars 23/July/2019
20:46
accurate Intraday Tips, accurate stock tips, BSE metal, Cash intraday tips, Market live
No comments
Nifty likely to open higher
The Nifty50 is expected to open higher on Tuesday following Asian markets which were trading mixed. Overnight, the S&P 500 climbed towards a record high supported by expectations of lower interest rates across the world. The European Central Bank meets on Thursday and money markets are pricing in a more than 50% chance of a 10-basis-point cut in interest rates. Federal Reserve officials are set to meet just days later, and are widely expected to lower rates by at least 25 basis points, said a Reuters report. Trends on SGX Nifty indicate a positive opening for the broader index in India, a rise of 18 points or 0.16 percent. Nifty futures were trading around 11,356-level on the Singaporean Exchange. The rupee depreciated by 12 paise to close at 68.92 against the US dollar on July 22 tracking heavy losses in the domestic equity market and a spike in crude oil prices following Iran's seizure of a British tanker.
Global Market:
Asian Markets: Asian markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.13% while the Hang Seng is up 0.15%. The Nikkei 225 is not trading.
US Markets: North and South American markets finished mixed as of the most recent closing prices. The Bovespa gained 0.48% and the S&P 500 rose 0.28%. The IPC lost 0.95%.
European Markets: European markets finished higher today with shares in France leading the region. The CAC 40 is up 0.26% while Germany's DAX is up 0.24% and London's FTSE 100 is up 0.08%.
Major Headlines of the day:
Rupee stands at 69.00 per dollar.
Hindustan Unilever Q1FY20E Result Expectation Moderation in rural growth; company is expected to report 6% yoy volume growth. Commentary on competition and pricing to watch out for.
ZEE Entertainment Q1FY20E Result Expectation Revenue to grow by 9.0% yoy; advertisement revenue to grow at a moderate rate. Commentary on stake sale to watch out for.
TVS Motor Q1FY20 PAT declines 2.9% yoy at Rs142.3cr The company reported revenue growth of 7.2% for the first quarter of FY20 at Rs4,469.8cr from Rs4,171cr in the quarter ended June 2018.
Earnings Reaction To Watch
LT
ZEEL
DCMSHRIRAM
HDFC LIFE
HINDUNILVR
JYOTHY LABS
KAJARIA CERAMIC
M&M FINANCIAL
LINDE IND
NIITTECH
SBILIFE
TORRENT PHARMA
Trend in FII flows:- The FIIs were Net Value of Rs -1916.91 segment while the DIIs were Net Value of 1829.90 the provisional figures.
Securities in Ban For Trade Date 23-JULY-2019
DISHTV
IDBI
DHFL
RELINFRA
Financial
Advisory Company in Indore, Stock
Advisory Company in Indore, Equity Tips, FreeTrading Tips , MCX Tips, sebi registered advisory company, Intraday
stock tips, Free
commodity tips
Investment trading in securities market is
always subjected to market risks, past performance is not a guarantee of future
performance. CapitalStars Investment Adviser: SEBI Registration Number:
INA000001647
For more details call
on 9977499927 or visit our website www.capitalstars.com
Subscribe to:
Posts (Atom)
















